オンファライトで苦しんでいる小牛の筋肉内投与後のアモキシシリンの薬理学研究とモデリング
Morgane Moustaghfir1, Bernadette Espana2, Karine Hauray3
1ANSES-Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.
Journal of veterinary pharmacology and therapeutics
|August 20, 2025
まとめ
炎の小牛の血濃度は非常に変動し,しばしば治療用値を下回った. 繰り返し投与したシミュレーションでは,感受性の高い細菌のブレイクポイントも達成できませんでした.
科学分野:
- 獣医薬学
- 薬理学
- 動物保健
背景:
- 乳首炎は乳首の感染症で 効果的な抗生物質治療が必要である.
- アモキシシリンとクラヴラニン酸 (AMC) は,獣医学でよく使用される抗菌剤です.
- 治療の有効性を最適化するために,病気の小牛におけるアモキシシリンの薬動性を理解することは極めて重要です.
研究 の 目的:
- オンファライトの小牛におけるアモキシシリン (AMX) の血薬動学的パラメータを推定する.
- 個々の小牛の間でAMXの薬動性を評価する.
- 確立されたブレイクポイントに基づいてAMXの潜在的な治療効果を評価する.
主な方法:
- アモキシシリンとクラブラン酸 (AMC) の単発筋内投与は,小牛 (n=7) に行われました.
- 投与後6時間以上のプラズマサンプル採取
- 液体染色体/質量スペクトロメトリー (LC-MS/MS) を用いたAMX濃度の定量化.
- モンテカルロシミュレーションを含む非区画および集団の薬理学分析.
主要な成果:
- 薬動学的パラメータ (Cl,Vd) の個体間での高い変動が観察されました.
- 最大血濃度 (Cmax) は1. 22から5. 99μg/ mlで,Tmaxは0. 75から2時間であった.
- 血AMX濃度は,繰り返し投与したシミュレーションでも,感受性の高いE. coliとPasteurella spp.のブレイクポイント4mg/L以下にとどまった.
結論:
- AMX/ AMCの単発およびシミュレートされた繰り返し投与は,炎の小牛において治療的濃度を達成できない可能性があります.
- 薬理学的な高変異性により,最適化される用量療法に関するさらなる研究が必要である.
- 現在の投与量は,この臨床シナリオにおいて,感受性の高い細菌感染を効果的に治療するには不十分である可能性があります.
関連する概念動画
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
495
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
495
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
137
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
137
One-Compartment Open Model for IV Bolus Administration: General Considerations
316
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
316
Two-Compartment Open Model: IV Bolus Administration
697
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
697
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
148
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
148


